Shilpa Medicare Ltd - 530549 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Shilpa Medicare's Board of Directors will meet on May 22, 2026, to consider and approve the audited Q4 & FY26 financial results. The board will also discuss a dividend recommendation for FY26.
May 14 2026 13:05:00
Shilpa Medicare Limited
Shilpa Medicare Limited appointed Dr. Vellaian Karuppiah as Chief Operating Officer, effective April 23, 2026. This appointment aims to strengthen the company's formulation business operations and enhance operational efficiencies, leveraging his 33 years of extensive pharmaceutical experience across R&D, regulatory, and manufacturing.
Apr 23 2026 21:04:00
Shilpa Medicare Limited
Shilpa Medicare appointed Dr. Vellaian Karuppiah as Chief Operating Officer – Formulations, effective April 23, 2026. This appointment aims to strengthen the company's formulation business operations and enhance efficiency, capitalizing on his 33 years of diverse pharmaceutical experience.
Apr 23 2026 09:04:00
Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Change in Management
Shilpa Medicare appointed Dr. Vellaian Karuppiah as Chief Operating Officer - Formulations, effective April 23, 2026. This appointment is expected to strengthen the company's formulation business operations and enhance operational efficiencies.
Apr 23 2026 09:04:00
Shilpa Medicare Limited
Shilpa Medicare announced the retirement of Mr. Jayant Karajgi, COO-Formulations, effective April 22, 2026. This marks a leadership change within the senior management team in the formulations segment.
Apr 22 2026 19:04:00
Shilpa Medicare Limited
Shilpa Medicare announced the retirement of Mr. Jayant Karajgi, COO-Formulations, effective April 22, 2026. This marks a leadership change within the senior management team in the formulations segment.
Apr 22 2026 19:04:00
Shilpa Medicare Limited
Shilpa Medicare announced the retirement of Dr. Jayant Karajgi, its Chief Operating Officer - Formulations, effective April 22, 2026. He will cease to be a Senior Management Personnel from this date.
Apr 22 2026 18:04:00
Read More